naratriptan has been researched along with Cholera Infantum in 1 studies
naratriptan: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Naratriptan was also more effective than placebo in reducing clinical disability and the incidences of nausea, photophobia, and phonophobia." | 2.68 | Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group. ( Asgharnejad, M; Laurenza, A; Mathew, NT; Peykamian, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mathew, NT | 1 |
| Asgharnejad, M | 1 |
| Peykamian, M | 1 |
| Laurenza, A | 1 |
1 trial available for naratriptan and Cholera Infantum
| Article | Year |
|---|---|
Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group.
Topics: Adolescent; Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Gastrointestinal Diseases; | 1997 |